Nanocarriers as a Delivery Platform for Anticancer Treatment: Biological Limits and Perspectives in B-Cell Malignancies

• Главные авторы: Sara Bozzer (Автор), Michele Dal Bo (Автор), Maria Cristina Grimaldi (Автор), Giuseppe Toffoli (Автор), Paolo Macor (Автор)
• Формат: ‌
• Опубликовано: MDPI AG, 2022-09-01T00:00:00Z.
• Предметы: article
• Online-ссылка: Connect to this object online.

Nanoparticle-based therapies have been proposed in oncology research using various delivery methods to increase selectivity toward tumor tissues. Enhanced drug delivery through nanoparticle-based therapies could improve anti-tumor efficacy and also prevent drug resistance. However, there are still p...